CU6 — Clarity Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Clarity Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18.9	92.3	65	137	84.1
Net Total Accounts Receivable
Net Total Receivables	3.37	6.66	10	12.6	10.1
Prepaid Expenses
Total Current Assets	22.5	99.6	76.7	154	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.093	0.26	0.206	0.555	0.552
Long Term Investments
Other Long Term Assets
Total Assets	22.6	99.8	76.9	155	101
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.25	7.51	7.54	8.09	10.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.34	7.59	7.72	8.33	10.9
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.3	92.2	69.2	146	90.2
Total Liabilities & Shareholders' Equity	22.6	99.8	76.9	155	101
Total Common Shares Outstanding